October 2011 Research News


Screening Mammograms Save Lives
October 24, 2011
A study estimates that screening mammograms save the lives of between 3% and 13% of all women aged 50 to 59 diagnosed with early-stage breast cancer. Read more...

Femara Offers More Benefits Than Tamoxifen After Breast Cancer Surgery
October 21, 2011
New results boost evidence that postmenopausal women get more benefits from 5 years of Femara compared to 5 years of tamoxifen after surgery for early-stage, hormone-receptor-positive breast cancer. Read more...

Radiation After Lumpectomy Offers Long-Term Benefits
October 19, 2011
A very large study has found that radiation therapy after lumpectomy offers more benefits and keeps offering the benefits much longer after diagnosis than doctors realized. Read more...

Annual Mammograms Find Cancer Earlier, but Cause More False Positives
October 17, 2011
A study has found that when women start getting mammograms at age 40, about 61% of them will be called back for more imaging tests because of a false-positive. Mammograms every other year lower the number of false positives, but increase the number of breast cancers detected at an advanced stage. Read more...

Some Women Benefit from Radiation Therapy After Mastectomy
October 9, 2011
Research suggests that women diagnosed with early-stage breast cancer that has spread to one or more underarm lymph nodes can benefit from radiation therapy after mastectomy. Read more...

Hormonal Therapy Before Surgery May Be Good Treatment for Postmenopausal Women with Hormone-Receptor-Positive, Locally-Advanced Disease
October 8, 2011
Research suggests that hormonal therapy before surgery may be a good alternative to chemotherapy before surgery for postmenopausal women diagnosed with hormone-receptor-positive breast cancer. Read more...

Treating Early-Stage, HER2-Positive Disease with Herceptin and Chemo Combo with No Anthracycline Reduces Heart Risks
October 5, 2011
A study has found that Herceptin plus chemotherapy that didn't include an anthracycline after surgery was as effective as Herceptin plus chemotherapy that included an anthracycline for women diagnosed with HER2-positive, early-stage breast cancer. Read more...

Side Effects Minimal for One Type of Partial-Breast Radiation
October 4, 2011
Early results suggest that the number and severity of side effects from 3-D conformal external beam radiation, a type of partial-breast irradiation, are low. Read more...

Blue Shield of California Will No Longer Pay for Avastin to Treat Advanced-Stage Breast Cancer
October 3, 2011
Blue Shield of California has announced it will no longer pay for bevacizumab (Avastin) to treat advanced breast cancer. This is the largest insurer to stop coverage since an FDA panel voted that the drug's breast cancer indication should be removed. Read more...

Survivors Need Ongoing, Long-Term Screening
October 2, 2011
Regular breast cancer screening for survivors saves lives and should be done for at least 10 years after diagnosis. Read more...

Was this resource helpful?

Yes No
C3a
C3b
Evergreen-donate
Back to Top